173 related articles for article (PubMed ID: 31205644)
1. Novel monoclonal antibody-based treatment strategies in adults with acute lymphoblastic leukemia.
Guerra VA; Jabbour EJ; Ravandi F; Kantarjian H; Short NJ
Ther Adv Hematol; 2019; 10():2040620719849496. PubMed ID: 31205644
[TBL] [Abstract][Full Text] [Related]
2. Antibody-based therapies in patients with acute lymphoblastic leukemia.
Dinner S; Liedtke M
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):9-15. PubMed ID: 30504286
[TBL] [Abstract][Full Text] [Related]
3. Recent updates for antibody therapy for acute lymphoblastic leukemia.
Li L; Wang Y
Exp Hematol Oncol; 2020 Nov; 9(1):33. PubMed ID: 33292550
[TBL] [Abstract][Full Text] [Related]
4. Advances in the treatment of adults with newly diagnosed B-cell acute lymphoblastic leukemia: the role of frontline immunotherapy-based regimens.
Short NJ; Kantarjian H; Jabbour E
Leuk Lymphoma; 2024 Jun; ():1-13. PubMed ID: 38850572
[TBL] [Abstract][Full Text] [Related]
5. Acute lymphoblastic leukemia in adults: encouraging developments on the way to higher cure rates.
Mathisen MS; Kantarjian H; Thomas D; O'Brien S; Jabbour E
Leuk Lymphoma; 2013 Dec; 54(12):2592-600. PubMed ID: 23547835
[TBL] [Abstract][Full Text] [Related]
6. Targeted inhibitors and antibody immunotherapies: Novel therapies for paediatric leukaemia and lymphoma.
Brivio E; Baruchel A; Beishuizen A; Bourquin JP; Brown PA; Cooper T; Gore L; Kolb EA; Locatelli F; Maude SL; Mussai FJ; Vormoor-Bürger B; Vormoor J; von Stackelberg A; Zwaan CM
Eur J Cancer; 2022 Mar; 164():1-17. PubMed ID: 35121370
[TBL] [Abstract][Full Text] [Related]
7. Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies.
Kyriakidis I; Vasileiou E; Rossig C; Roilides E; Groll AH; Tragiannidis A
J Fungi (Basel); 2021 Mar; 7(3):. PubMed ID: 33807678
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and management of measurable residual disease in acute lymphoblastic leukemia.
Abou Dalle I; Jabbour E; Short NJ
Ther Adv Hematol; 2020; 11():2040620720910023. PubMed ID: 32215194
[TBL] [Abstract][Full Text] [Related]
9. CD22 Expression in B-Cell Acute Lymphoblastic Leukemia: Biological Significance and Implications for Inotuzumab Therapy in Adults.
Lanza F; Maffini E; Rondoni M; Massari E; Faini AC; Malavasi F
Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 32012891
[TBL] [Abstract][Full Text] [Related]
10. SOHO State of the Art Updates and Next Questions | Novel Agents and the Diminishing Role of Allogeneic Stem Cell Transplant in B-Acute Lymphoblastic Leukemia.
Jen WY; Jabbour E; Kantarjian HM; Short NJ
Clin Lymphoma Myeloma Leuk; 2024 Mar; ():. PubMed ID: 38538495
[TBL] [Abstract][Full Text] [Related]
11. Recent advances and novel treatment paradigms in acute lymphocytic leukemia.
Papadantonakis N; Advani AS
Ther Adv Hematol; 2016 Oct; 7(5):252-269. PubMed ID: 27695616
[TBL] [Abstract][Full Text] [Related]
12. Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
Gibson A; Nunez C; Robusto L; Kammerer B; Garcia M; Roth M; Sheth R; Tewari P; Hittle A; Toepfer L; Torres R; Short NJ; Jabbour E; Jain N; Cuglievan B; McCall D
Haematologica; 2024 May; ():. PubMed ID: 38779719
[TBL] [Abstract][Full Text] [Related]
13. SOHO State of the Art Updates and Next Questions | Approach to Older Adults With Phildadelphia-Chromosome Negative Acute Lymphoblastic Leukemia.
Shimony S; Luskin MR
Clin Lymphoma Myeloma Leuk; 2024 Mar; 24(3):133-140. PubMed ID: 38102012
[TBL] [Abstract][Full Text] [Related]
14. Antibody therapy for pediatric leukemia.
Vedi A; Ziegler DS
Front Oncol; 2014; 4():82. PubMed ID: 24795859
[TBL] [Abstract][Full Text] [Related]
15. Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions.
Samra B; Jabbour E; Ravandi F; Kantarjian H; Short NJ
J Hematol Oncol; 2020 Jun; 13(1):70. PubMed ID: 32503572
[TBL] [Abstract][Full Text] [Related]
16. Targeted therapy paves the way for the cure of acute lymphoblastic leukaemia.
Rafei H; Kantarjian HM; Jabbour EJ
Br J Haematol; 2020 Jan; 188(2):207-223. PubMed ID: 31566728
[TBL] [Abstract][Full Text] [Related]
17. Management of adverse effects of new monoclonal antibody treatments in acute lymphoblastic leukemia.
Conde-Royo D; Juárez-Salcedo LM; Dalia S
Drugs Context; 2020; 9():. PubMed ID: 33110433
[TBL] [Abstract][Full Text] [Related]
18. Dasatinib-Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults.
Foà R; Bassan R; Vitale A; Elia L; Piciocchi A; Puzzolo MC; Canichella M; Viero P; Ferrara F; Lunghi M; Fabbiano F; Bonifacio M; Fracchiolla N; Di Bartolomeo P; Mancino A; De Propris MS; Vignetti M; Guarini A; Rambaldi A; Chiaretti S;
N Engl J Med; 2020 Oct; 383(17):1613-1623. PubMed ID: 33085860
[TBL] [Abstract][Full Text] [Related]
19. Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia.
Rambaldi A; Ribera JM; Kantarjian HM; Dombret H; Ottmann OG; Stein AS; Tuglus CA; Zhao X; Kim C; Martinelli G
Cancer; 2020 Jan; 126(2):304-310. PubMed ID: 31626339
[TBL] [Abstract][Full Text] [Related]
20. Moving immunotherapy into the front line in ALL.
Winters A; Gore L
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):209-217. PubMed ID: 31808875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
